This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo
Clinical Summary

Low serum creatinine levels linked to increased risk for T2DM and dysglycaemia

Takeaway

  • Low serum creatinine level was found to be significantly associated with increased risk for type 2 diabetes mellitus (T2DM) and dysglycaemia.

Why this matters

  • The study showed that serum creatinine may be an important modifiable risk factor and may be indicative of dysglycaemia risk, providing an opportunity for prevention of T2DM.

Study design

  • Retrospective cohort study included 3313 middle-aged men with no T2DM identified during 2001-2008 who underwent follow-up examinations until March 2013.
  • Participants underwent an interview at baseline and were followed for 6.7 years.
  • Funding: None.

Key results

  • Overall, 207 cases of incident T2DM and 596 cases of incident dysglycaemia, including 115 cases of type 2 diabetes mellitus, among participants with normal glucose concentrations at baseline was observed.
  • After adjustments, the HR of patients with T2DM in the lowest quartile of serum creatinine (<0.7 mg/dL) vs patients in the highest quartile (0.9-1.1 mg/dL) was 1.9 (95% CI, 1.2-2.9; P for trend=.03).
  • The HR of dysglycaemia in the lowest quartile of serum creatinine vs highest quartile was 1.5 (95% CI, 1.1-1.9; P for trend=.01).

Limitations

  • Only male participants from a single ethnic group were included.
  • Fasting serum insulin at baseline was not assessed.

References


YOU MAY ALSO LIKE